Search Results
A "chemo-sparing" MRD-driven strategy for CLL
Is chemotherapy still a valid treatment for CLL?
CLL: Rationale for Ibrutinib and Chemotherapy
Front-line use of ibrutinib for CLL in a real-world setting
Current treatment options for CLL
"Sequential triple-T" therapy for CLL
How do we sequence and combine novel agent-based therapies in CLL?
Should standard chemotherapy regimens be altered in favor of small molecules? iFCG for frontline CLL
Ibrutinib combination therapy in CLL: overview of the data so far
Are newer, targeted agents better for the management of untreated CLL than chemoimmunotherapy?
The High Risk Patient
ASH 2017: combination therapy for CLL highlights
